Recent advances in pharmacological treatment of type 2 diabetes mellitus.
Several new pharmacological agents attempt to correct abnormalities in the pathogenesis of type 2 diabetes mellitus. The availability of agents with different mechanisms of action and side-effect profiles permits the design of individualized regimens that address the various pathophysiologic abnormalities.
Parulkar
A A
AA
Department of Medicine, Tulane University Medical Center, New Orleans, LA 70112-2699, USA.
Fonseca
V A
VA
D001786:Blood Glucose; D003131:Combined Modality Therapy; D003924:Diabetes Mellitus, Type 2 / Q000175:diagnosis / Q000178:diet therapy* / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D015444:Exercise; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D008297:Male; D011379:Prognosis; D015431:Weight Loss
D001786:Blood Glucose; D007004:Hypoglycemic Agents